Send us a text

 Summary:  neffy® nasal spray received fast track approval from the FDA on August 9, 2024 for the emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weight at least 66 pounds.  This may be a gamechanger in that it provides emergency epinephrine treatment for anaphylaxis without needles.  But, as with all medications, correct use and monitoring is necessary.  

Topics

·       Fast Track Approval 01:30

·       $$$                          03:15

·        Minimum Weight 66 pounds 04:15

·       Approval Process 06:00

·       Pharmacokinetics & Pharmacodynamics 07:00

·       Epi Mechanism of Action 08:00

·       How to use neffy 10:45

·       Storage 13:00

·       Gamechanger? 15:00

·       risk – BENEFIT 16:20

·       Dosing (1/2 Life) 18:25

·       Storage 22:15

Questions and comments to [email protected]